A hypothesis-driven approach identifies CDK4 and CDK6 inhibitors as candidate drugs for treatments of adrenocortical carcinomas.
about
DNA damage response induced by Etoposide promotes steroidogenesis via GADD45A in cultured adrenal cells.Drug repurposing using high-throughput screening identifies a promising drug combination to treat adrenocortical carcinomaAdvances in adrenal tumors 2018Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era
P2860
A hypothesis-driven approach identifies CDK4 and CDK6 inhibitors as candidate drugs for treatments of adrenocortical carcinomas.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A hypothesis-driven approach i ...... of adrenocortical carcinomas.
@en
A hypothesis-driven approach i ...... of adrenocortical carcinomas.
@nl
type
label
A hypothesis-driven approach i ...... of adrenocortical carcinomas.
@en
A hypothesis-driven approach i ...... of adrenocortical carcinomas.
@nl
prefLabel
A hypothesis-driven approach i ...... of adrenocortical carcinomas.
@en
A hypothesis-driven approach i ...... of adrenocortical carcinomas.
@nl
P2093
P2860
P356
P1433
P1476
A hypothesis-driven approach i ...... of adrenocortical carcinomas.
@en
P2093
Chrystelle Maric
Djihad Hadjadj
Fabien Fauchereau
Giuseppe Baldacci
Laura Ben Driss
Su-Jung Kim
P2860
P304
P356
10.18632/AGING.101356
P577
2017-12-26T00:00:00Z